Cardiac Diabetic PCD Pharma Franchise
Cardiac Diabetic PCD Pharma Franchise – Heart disease and diabetes have been rising in India in recent decades. The number of people dealing with diabetes has increased 2.5 times from 26 million in 1990 to 265 million in 2024. Today’s Indian youth is on the radar of heart disease due to diabetes. Globally, the demand for diabetic drugs is impressive. In the year 2018, the demand for diabetic drugs increased, offering a whopping profit of $48,753.1 million, and by the year 2026, the price or the market value is over $78,261.7 million.
Cardiovascular medicines in the year 2018 experienced a rise of $47.29 billion, while it is expected to reach a market value of $63.96 billion by 2026.
Together, the cardiac diabetic products have managed to attain a profit of $900 billion in the year 2024, as these have increased with a growth rate of CAGR 10%. The Diabetic products in the year 2024 are worth $98.102 billion and can increase further by $68.38 billion in the year 2024.
To promote and develop cardiac diabetic healthcare, Servocare Lifesciences is here with its quality-oriented products. The company has made its notable presence in the pharma industry for the cardiac and diabetic range. Along with the expansion of our quality product range, we are also providing Cardiac Diabetic PCD Pharma Franchise business opportunities in the Pan-India Region.
Diabetes has affected a huge population and has been considered a serious health problem. Lots of cases of cardiac diabetes are increasing every month. The demand for cardiac diabetic medicines has increased in the market. The business seekers and pharma companies who are dealing in this range are getting permanent customers due to open-ended demand and also earning great profit in return. Thus Cardiac Diabetic PCD Franchise has been witnessed as a lucrative business deal for pharma professionals and even newcomers.
Servocare Lifesciences is one of the top cardiac diabetic PCD Companies in India. You can get to know more about our company and its cardiac diabetic PCD franchise services by calling us at +919875921201. You can also connect with us via email at servocaregroup@gmail.com. Our team of representatives will respond to your query as soon as possible.
Top Cardiac Diabetic PCD Franchise Company in India
Pharma products manufacturing is a highly competitive field, and thus, only the best can survive. Servocare Lifesciences is leading in the pharma industry because of its effective pharma formulations and astounding PCD franchise services.
Diabetes is the latest lifestyle disease that many are prone to. Here is a market analysis of 2024 by the medical researchers of the USA that describes the condition and number of people suffering from diabetes.
Being a top cardiac diabetic company, we guarantee convenient and easy access to pharmaceutical formulations because of our enormous and wide network throughout the country. Our pharma organization is emerging swiftly with its great and deep exposure in the zone of cardiac diabetic range of products. We have succeeded in delivering 150+ products in cardiac and diabetic products, all suitable for Cardiac Diabetic PCD Pharma Franchise in India.
Here we have listed some of the highlights of our company:
- The company is ISO-certified and deals in products that are WHO-GMP certified.
- DCGI and FSSAI-approved products are supplied from our end.
- Along with the marketing of products, we are also providing third-party pharma manufacturing.
- We have opened the doors of opportunity for the stockists, retailers, market representatives, wholesalers, entrepreneurs, and even beginners.
Grab Cardiac Diabetic PCD Franchise Opportunity in India 2024
As per the analysis, the pharmaceutical industry is witnessing 25% growth in diabetes. In India, the overall anti-diabetes market was worth $680.3m in 2011 and is expected to grow at a CAGR of 11.3% between 2011 and 2024 to reach $1446m in 2024. The demand for cardiac drugs in the pharma market will expand at a compound annual growth rate of as much as 11% and account for around 50% of growth in product spending in 2024.
The above analysis is strong enough to state the demand for cardiac products in the market, as many people suffer from the condition of heart attacks, heart strokes, etc. The infographic below describes the research statistics done by the American Heart Association.
Servocare Lifesciences offers the best range of pharmaceutical Products to pharma professionals who are willing to start a Diabetic PCD Franchise with less investment and good scope. All the products are highly suitable for the Cardiac Diabetic PCD Franchise. Owing to the rich experience of the medical experts at Servocare, we are among the best-known names in the diabetic medicine market. Some of the popular and most demanded diabetic medicines are the following:
- Sitagliptin.
- Antidiabetic Medicine.
- Insulin Pen.
- Metformin Tablets.
- Metformin Hydrochloride.
- Glibenclamide.
- Glimepiride.
- Voglibose.
Quality Cardiac Product Range for Pharma Franchise
Servocare is a well-known and trusted name in the pharmaceutical sector. Over the past few years, the company has emerged as the best choice for Cardiac products. Be it the quality, effectiveness, safety, affordability, or anything, we are the first preference for pharma professionals. You can choose the products for the Cardiac Diabetic PCD Pharma Franchise in the Pan-India region. Here are the products we offer to our cardiac PCD Franchise partners in PAN India:
- Anticoagulants
- Vasodilators etc
- Cholesterol-lowering medications
- Diuretics
- ACE Inhibitors
- Digitalis Preparations
- Angiotensin II Receptor Blockers
- Angiotensin
- Calcium Channel Blockers
Extensive Quality Products for Cardiac Diabetic PCD Franchise
At Servocare Lifesciences, quality is never neglected. We keep quality as our topmost priority. Our formulation regulatory department is focused on bringing the latest molecules to our markets with expedience, thereby guaranteeing a regular flow of updated products to our customers. The product range is suitable for Cardiac Diabetic PCD Franchise in India and adheres to all the regulatory norms and international manufacturing standards.
We work with a wide network of distributors, programmatically and strategically, to expand, accelerate, and extend the product life cycles of cardiac medicines. The organization has developed an astounding brand marketing experience in emerging markets through its portfolio of cardiac diabetic products.
Go through our cardiac diabetic quality formulations:
Cardiac Range for PCD Pharma Franchise
Here are some of our compositions with brand names available for the Cardiac PCD Franchise:
| PRODUCT NAME | COMPOSITION |
|---|---|
| Altovas 10 | Atorvastatin 10mg |
| Altovas 20 | Atorvastatin 20mg |
| Altovas 40 | Atorvastatin 40mg |
| Altovas C | Atorvastatin 40mg + Clopidogrel 75mg |
| Altovas E | Atorvastatin 40mg + Ezetemibe 10mg |
| Altovas F | Atorvastatin 40mg + Fenofibrate 160mg |
| Amlorax 5 | Amlodipine 5mg |
| Amlorax AT | Amlodipine 5mg + Atenolol 50mg |
| Amlorax H | Amlodipine 5mg + Hydrochlorothiazide 12.5mg |
| Artinex | Nitroglycerine 2.6mg |
| Cardipace 2.5 | Nebivolol 2.5mg |
| Cardipace 5 | Nebivolol 5mg |
| Cardipace AM | Nebivolol 5mg + Amlodipine 5mg |
| Cardipace H | Nebivolol 5mg + Hydrochlorothiazide 12.5mg |
| Lestra 25 | Losartan Potassium 25mg |
| Lestra 50 | Losartan Potassium 50mg |
| Lestra H | Losartan Potassium 50mg + Hydrochlorothiazide 12.5mg |
| Micard 2.5 | Ramipril 2.5mg |
| Micard 5 | Ramipril 5mg |
| Micard AM | Ramipril 2.5mg + Amlodipine 5mg |
| Olivest 120 | Orlistat 120mg |
| Olzart 20 | Olmesartan 20mg |
| Olzart 40 | Olmesartan 40mg |
| Olzart H | Olmesartan 20mg + Hydrochlorothiazide 12.5mg |
| Rosuvest 10 | Rosuvastatin 10mg |
| Rosuvest 20 | Rosuvastatin 20mg |
| Rosuvest F | Rosuvastatin 10mg + Fenofibrate 160mg |
| Telizart 20 | Telmisartan 20mg |
| Telizart 40 | Telmisartan 40mg |
| Telizart 40H | Telmisartan 40mg + Hydrochlorothiazide 12.5mg |
| Telizart 80H | Telmisartan 80mg + Hydrochlorothiazide 12.5mg |
| Telizart AH | Telmisartan 80mg + Amlodipine 5mg + Hydrochlorothiazide 12.5mg |
| Telizart CD | Telmisartan 40mg + Clinidipine 10mg |
Diabetic Range for PCD Pharma Franchise
Have a look at our exclusive range of Diabetic Range for PCD Franchise business in India. All these products come with the best quality packaging. This provides our products a long shelf life and saves them from getting tempered:
| PRODUCT NAME | COMPOSITION |
|---|---|
| Glyrax 1 | Glimepiride 1mg |
| Glyrax 2 | Glimepiride 2mg |
| Glyrax M1 | Glimepride 1mg + Metformin 500mg |
| Glyrax M2 | Glimepride 2mg + Metformin 500mg |
| Metaglax 1000 | Metformin 1000mg SR |
| Metaglax 500 | Metformin 500mg SR |
| Metaglax G | Gliclazide 80mg + Metformin 500mg |
Collaborate for Lucrative Cardiac and Diabetic PCD Franchise Business in India
Servocare Lifesciences enables the business partners to get the shared payback to cultivate in their areas; thus, we make available to them the best assistance.
Below are the cardiac and diabetic products franchise services provided by us:
Promotional Assistance – The company provides preeminent promotional and marketing support to its cardiac diabetic franchise associates. Our promotional kit includes visual aids, visiting cards, diaries, brochures, written pads, reminder cards, samples, etc.
Sophisticated Packaging and Quick Delivery – All our products come with superior quality and eye-catching packaging. This helps us maintain the quality of our products. Our team ensures to delivery of the products at the right time.
Unique Monopoly Rights – The exclusive monopoly rights assist investors in running their business better. Our offered monopoly rights benefit both parties. The superior distribution right is transferred to our partners through a monopoly-based PCD franchise.
Invest in the Cardiac and Diabetic PCD Franchise business to become ingrained in the pharmaceutical industry successfully.
Quality assurance of Cardiac and Diabetic Range Products
Our prime responsibility is delivering quality products to our customers. The diligent team of experts has steadily worked on improving the whole product segment. The quality controller supervises the manufacturing procedure thoroughly and tests each product’s quality on various parameters. Our product list is certified by DCGI & FSSAI.
The experts opted for all the latest and modern technologies to bring innovations in the medications. Every year, we add 50+ new products to our product portfolio, which comprises new and unique combinations. Defective pieces are rejected during the time of quality checking. Our products are the base of our foundation in the market.
Benefits of Partnering With Servocare for Cardiac Diabetic PCD Pharma Franchise
Servocare follows a customer-centric approach to ensure 100% customer satisfaction with all business associates. These benefits give you a competitive edge in the market and establish a strong brand presence in the market. The wide range of benefits you can enjoy by associating with Servocare for Cardiac Diabetic PCD Pharma Franchise is mentioned below:
- 100% Quality Assurance
- Assured availability of products
- High Margins because of fair prices
- 100% monopoly Guaranteed
- Free Promotional Support Enriched Product Basket
- Attractive Packaging
- 25 years of experience
- Reliability of ISO 9001:2015 Certification
- Same-day dispatch with 24-hour support service
Best Cardiac Diabetic PCD Franchise Deals At Servocare Life Sciences
At present, India represents 49% of the world’s diabetes burden with an anticipated 72 million cases in 2017. The stats for Cardiac health issues are even worse. There is thus a huge demand for quality Cardiac Diabetic products in India. Finding the right cardiac and diabetic PCD Pharma Company seems daunting when there are a huge number of companies present online. However, finding the right company can help you earn a good profit and help grow your business. Here at Servocare, we will let you know what makes us the best for Cardiac Diabetic PCD Pharma Franchise in India:
- Our Company is dedicated to delivering the best quality pharmaceutical products. Thus, we have a quality assurance team that keeps a good check on the quality of every product.
- Availability of stock all the time.
- The Company has set up its manufacturing unit in an excise duty-free zone, which helps in keeping the price of medicine lower than our competitors in the market.
- Our Cardiac Diabetic PCD Franchise Business partners get free promotional benefits from our end.
- Regularly introduce or launch new products in the market as per the new requirements.
- Follow complete norms and regulations set by the WHO, GMP, DCGI, and ISO.
Steps on How You Can Start a PCD Franchise in India
Starting a Cardiac Diabetic PCD Pharma Franchise
in India with Servocare Lifesciences is a simple and transparent process. Here’s a step-by-step roadmap for aspiring pharma professionals:
- Get in Touch: Call us at +919875921201 or email us at servocaregroup@gmail.com to share your interest.
- Location Finalization: Choose your preferred business location. We provide monopoly-based rights, ensuring you get exclusive control in your area.
- Product Selection: Select from our wide range of 150+ cardiac and diabetic medicines including tablets, capsules, injectables, and more.
- Agreement & Documentation: Complete the franchise agreement and submit the required documents (Drug License, GST, etc.) with ease.
- Business Kick-Off: Receive your promotional kit, product stock, and marketing support from us. Start your own franchise business with full Servocare support.
Contact Information
Name:- Servocare Lifesciences
Marketing Office-1
Plot No 351, Industrial Area, Phase-1, Panchkula, Haryana (134113)
Marketing Office-2
Plot No: 352, Industrial Area, Phase : 1, Panchkula Haryana (134113)
Mobile No:- +919875921201
Email ID:- servocaregroup@gmail.com
We offer the following ranges in PCD Pharma Franchise
- Gynecology Product Range
- Pediatric Product Range
- Ophthalmic Product Range
- Cardiac-Diabetic Product Range
Frequently Asked Questions
Q1. What is the scope of the Cardiac Diabetic PCD Pharma Franchise in India?
The demand for cardiac and diabetic medicines is growing rapidly due to lifestyle-related health issues. With India having one of the largest diabetic populations, this sector promises consistent growth and high profits.
Q2. How much investment is required to start?
The investment is flexible depending on the location and product range. Servocare ensures a low-risk, high-return model suitable for both beginners and experienced pharma professionals.
Q3. Does Servocare provide monopoly rights?
Yes. We offer exclusive monopoly rights so that our franchise partners can operate in their chosen area without facing competition from within our own network.
Q4. What promotional support will I get?
We provide free promotional material such as visual aids, visiting cards, product samples, reminder cards, diaries, and more to help you market effectively.
Q5. Why should I choose Servocare Lifesciences?
Servocare Lifesciences is an ISO-certified company with DCGI-approved products, WHO-GMP manufacturing standards, 25+ years of experience, and a trusted presence across India.